INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 253 filers reported holding INARI MED INC in Q3 2023. The put-call ratio across all filers is 3.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $115,018,915 | +11.5% | 1,758,699 | -0.9% | 0.01% | +20.0% |
| Q2 2023 | $103,189,953 | +0.7% | 1,774,853 | +6.9% | 0.01% | -16.7% |
| Q1 2023 | $102,481,917 | -49.4% | 1,659,895 | -47.9% | 0.01% | 0.0% |
| Q4 2022 | $202,548,558 | +79.6% | 3,186,730 | +105.3% | 0.01% | -14.3% |
| Q3 2022 | $112,781,000 | +27.3% | 1,552,608 | +19.2% | 0.01% | +40.0% |
| Q2 2022 | $88,581,000 | +33.9% | 1,302,857 | +78.6% | 0.01% | +66.7% |
| Q1 2022 | $66,134,000 | -0.4% | 729,630 | +0.3% | 0.00% | 0.0% |
| Q4 2021 | $66,397,000 | +10.3% | 727,484 | -2.0% | 0.00% | 0.0% |
| Q3 2021 | $60,178,000 | +1.3% | 742,020 | +16.5% | 0.00% | 0.0% |
| Q2 2021 | $59,415,000 | +47.5% | 636,953 | +69.1% | 0.00% | +50.0% |
| Q1 2021 | $40,294,000 | +72.1% | 376,581 | +40.4% | 0.00% | +100.0% |
| Q4 2020 | $23,416,000 | +190.4% | 268,257 | +129.6% | 0.00% | 0.0% |
| Q3 2020 | $8,063,000 | – | 116,826 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darsana Capital Partners LP | 1,475,000 | $137,588,000 | 3.91% |
| Affinity Asset Advisors, LLC | 85,000 | $7,929,000 | 2.84% |
| Parian Global Management LP | 49,800 | $4,645,000 | 1.99% |
| AlpInvest Partners B.V. | 27,960 | $2,608,000 | 1.28% |
| Sio Capital Management, LLC | 46,332 | $4,322,000 | 1.07% |
| HARBOURVEST PARTNERS LLC | 88,598 | $8,264,000 | 0.79% |
| HAMILTON LANE ADVISORS LLC | 26,403 | $2,463,000 | 0.77% |
| Pier Capital, LLC | 76,708 | $7,155,000 | 0.72% |
| Lisanti Capital Growth, LLC | 46,035 | $4,294,000 | 0.53% |
| NEXT CENTURY GROWTH INVESTORS LLC | 66,822 | $6,233,000 | 0.49% |